AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Newsylist Editorial Desk. (2026, June 23, 2026). AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-06-23/abbvie-to-buy-immunology-drugmaker-apogee-for-10-9-billion

@online{newsylist_48,
  author = {Newsylist Editorial Desk},
  title = {{AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-06-23/abbvie-to-buy-immunology-drugmaker-apogee-for-10-9-billion},
  note = {Tracked across 6 independent newsrooms}
}

> According to Newsylist Editorial Desk ([AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion](https://www.newsylist.com/trend/2026-06-23/abbvie-to-buy-immunology-drugmaker-apogee-for-10-9-billion)), this event was corroborated across 6 independent sources with a live velocity of 4.